188 related articles for article (PubMed ID: 30594702)
1. Performance evaluation of the Bio-Rad Geenius HIV 1/2 supplemental assay.
Luo W; Sullivan V; Smith T; Peters PJ; Gay C; Westheimer E; Cohen SE; Owen SM; Masciotra S
J Clin Virol; 2019 Feb; 111():24-28. PubMed ID: 30594702
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population.
Kondo M; Sudo K; Sano T; Kawahata T; Itoda I; Iwamuro S; Yoshimura Y; Tachikawa N; Kojima Y; Mori H; Fujiwara H; Hasegawa N; Kato S
PLoS One; 2018; 13(10):e0198924. PubMed ID: 30379808
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
Fordan S; Bennett B; Lee M; Crowe S
J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
Montesinos I; Eykmans J; Delforge ML
J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.
Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S
J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as Part of a Confirmatory HIV Testing Strategy for Quebec, Canada: Comparison with Western Blot and Inno-Lia Assays.
Serhir B; Desjardins C; Doualla-Bell F; Simard M; Tremblay C; Longtin J
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944187
[TBL] [Abstract][Full Text] [Related]
8. Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays.
Tuaillon E; Sanosyan A; Pisoni A; Liscouët J; Makinson A; Perre PV
J Clin Virol; 2017 Oct; 95():47-51. PubMed ID: 28843384
[TBL] [Abstract][Full Text] [Related]
9. Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay.
Wesolowski LG; Chavez PR; Cárdenas AM; Katayev A; Slev P; Valsamakis A; Wang YF; Yao JD; Dougherty C; Gillim-Ross L; Harmon C; Delaney KP
Sex Transm Dis; 2020 May; 47(5S Suppl 1):S13-S17. PubMed ID: 32343517
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
[TBL] [Abstract][Full Text] [Related]
11. Qualification of the Geenius HIV 1/2 supplemental assay for use in the HIV blood donation screening algorithm.
Saá P; Townsend RL; Wells P; Janzen MA; Brodsky JP; Stramer SL
Transfusion; 2020 Aug; 60(8):1804-1810. PubMed ID: 32339301
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Geenius HIV-1/2 Confirmatory Assay for the confirmatory and differential diagnosis of HIV-1/HIV-2 in Japan and reliability of the Geenius Reader in the diagnosis of HIV-2.
Kusagawa S; Kawana-Tachikawa A; Matsubayashi K; Hoshi Y; Ishimaru K; Hamaguchi I
BMC Infect Dis; 2021 Jun; 21(1):569. PubMed ID: 34126953
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Bio-Rad Geenius HIV 1/2 Confirmation Assay as an Alternative to Western Blot in the Korean Population: A Multi-Center Study.
Moon HW; Huh HJ; Oh GY; Lee SG; Lee A; Yun YM; Hur M
PLoS One; 2015; 10(9):e0139169. PubMed ID: 26422281
[TBL] [Abstract][Full Text] [Related]
14. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of the Multispot HIV-1/HIV-2 rapid test to correctly differentiate HIV-2 from HIV-1 infection in screening algorithms using third and fourth generation assays and to identify cross reactivity with the HIV-1 Western Blot.
Ramos EM; Harb S; Dragavon J; Coombs RW
J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e104-7. PubMed ID: 24342468
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results.
Michaeli M; Wax M; Gozlan Y; Rakovsky A; Mendelson E; Mor O
J Clin Virol; 2016 Mar; 76():1-3. PubMed ID: 26761545
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
Keating SM; Kassanjee R; Lebedeva M; Facente SN; MacArthur JC; Grebe E; Murphy G; Welte A; Martin JN; Little S; Price MA; Kallas EG; Busch MP; Pilcher CD
J Acquir Immune Defic Syndr; 2016 Dec; 73(5):581-588. PubMed ID: 27509247
[TBL] [Abstract][Full Text] [Related]
18. Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation.
Wong CC; Lim SH; Tan CT; Lui SY; Lee YL; Chan KP
PLoS One; 2018; 13(6):e0199502. PubMed ID: 29928045
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.
Cárdenas AM; Baughan E; Hodinka RL
J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294
[TBL] [Abstract][Full Text] [Related]
20. The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.
Pandori MW; Westheimer E; Gay C; Moss N; Fu J; Hightow-Weidman LB; Craw J; Hall L; Giancotti FR; Mak ML; Madayag C; Tsoi B; Louie B; Patel P; Owen SM; Peters PJ
J Clin Virol; 2013 Dec; 58 Suppl 1():e92-6. PubMed ID: 24342485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
